NL7304881A - - Google Patents

Info

Publication number
NL7304881A
NL7304881A NL7304881A NL7304881A NL7304881A NL 7304881 A NL7304881 A NL 7304881A NL 7304881 A NL7304881 A NL 7304881A NL 7304881 A NL7304881 A NL 7304881A NL 7304881 A NL7304881 A NL 7304881A
Authority
NL
Netherlands
Application number
NL7304881A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7304881A publication Critical patent/NL7304881A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7304881A 1972-04-10 1973-04-09 NL7304881A (cs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1645172A GB1432563A (en) 1972-04-10 1972-04-10 Platinum- co-ordination compounds
GB2139072 1972-05-08

Publications (1)

Publication Number Publication Date
NL7304881A true NL7304881A (cs) 1973-10-12

Family

ID=26252050

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7304881A NL7304881A (cs) 1972-04-10 1973-04-09

Country Status (7)

Country Link
US (1) US3904663A (cs)
JP (1) JPS535369B2 (cs)
DE (1) DE2318021A1 (cs)
FR (1) FR2182942B1 (cs)
GB (1) GB1432563A (cs)
NL (1) NL7304881A (cs)
SE (1) SE396755B (cs)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419340A (en) * 1969-03-24 1983-12-06 University Of Delaware Controlled release of anticancer agents from biodegradable polymers
GB1578323A (en) * 1976-02-26 1980-11-05 Rustenburg Platinum Mines Ltd Compositions containing platinum
GB1585103A (en) * 1976-04-06 1981-02-25 Rustenburg Platinum Mines Ltd Pharmaceutical compositions containing platinum compounds
US4255417A (en) * 1976-08-04 1981-03-10 Johnson Matthey, Inc. Platinum compounds for the irradication of skin blemishes
US4115418A (en) * 1976-09-02 1978-09-19 Government Of The United States Of America 1,2-diaminocyclohexane platinum (ii) complexes having antineoplastic activity
JPS6041077B2 (ja) * 1976-09-06 1985-09-13 喜徳 喜谷 １，２‐ジアミノシクロヘキサン異性体のシス白金（２）錯体
US4278660A (en) * 1977-05-02 1981-07-14 Research Corporation Complex or salt of a platinum (II) compound and a nitrogen containing polymer
US4151185A (en) * 1977-05-02 1979-04-24 Research Corporation Complex or salt of a platinum (II) compound and a nitrogen containing polymer
US4137248A (en) * 1977-08-29 1979-01-30 The United States Of America As Represented By The Department Of Health, Education And Welfare Compound, 4-carboxyphthalato(1,2-diaminocyclohexane)-platinum(II) and alkali metal salts thereof
JPS5829957B2 (ja) * 1977-09-12 1983-06-25 喜徳 喜谷 新規な白金錯体
US4225529A (en) * 1977-10-19 1980-09-30 Johnson, Matthey & Co., Limited Compositions containing platinum
US4230631A (en) * 1977-10-19 1980-10-28 Johnson, Matthey & Co., Limited Platinum coordination compounds
DE2845371A1 (de) * 1977-10-19 1979-04-26 Johnson Matthey Co Ltd Platinkomplexverbindung, pharmazeutische stoffzusammensetzung mit einer solchen verbindung und deren anwendung
NL7807334A (nl) * 1978-07-06 1980-01-08 Tno Platina-diaminecomplexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een genees- middel met toepassing van een dergelijk platina-dia- minecomplex voor de behandeling van kanker, alsmede al- dus verkregen gevormd geneesmiddel.
US4405757A (en) * 1979-09-14 1983-09-20 Howell Bobby A Macromolecular complexes of amidocarbonylic water-soluble polymers and square planar platinous and equivalent organometallics
US4578491A (en) * 1982-06-28 1986-03-25 Engelhard Corporation Bis(thiocyanato)palladium(II) complexes
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
US4560782A (en) * 1982-11-19 1985-12-24 Research Corporation Anti-tumor diplatinum coordination compounds
US4533502A (en) * 1983-02-22 1985-08-06 Rochon Fernande D Platinum (II) compounds and their preparation
WO1984004524A1 (en) * 1983-05-10 1984-11-22 Andrulis Res Corp Bis-platinum complexes as antitumor agents
US4544759A (en) * 1983-07-29 1985-10-01 American Cyanamid Company Platinum complexes of antitumor agents
US4588831A (en) * 1984-11-09 1986-05-13 Natec Platinum complex compounds of substituted 5,8-dihydroxyl-1,4-naphthoquinone, and process for their production and use
US5384127A (en) * 1985-10-18 1995-01-24 Board Of Regents, The University Of Texas System Stable liposomal formulations of lipophilic platinum compounds
US5117022A (en) * 1985-10-18 1992-05-26 The Board Of Regents, The University Of Texas System Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
US5041581A (en) * 1985-10-18 1991-08-20 The University Of Texas System Board Of Regents Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
US5393909A (en) * 1988-11-22 1995-02-28 Board Of Regents, The University Of Texas System Diamine platinum complexes as antitumor agents
US5041578A (en) * 1988-11-22 1991-08-20 Board Of Regents, The University Of Texas System Water soluble 1,2-diaminocyclohexane platinum (IV) complexes as antitumor agents
US5434256A (en) * 1988-11-22 1995-07-18 Board Of Regents, The University Of Texas System Diamine platinum complexes as antitumor agents
US5843475A (en) * 1996-12-06 1998-12-01 Board Of Regents, The University Of Texas System Delivery and activation through liposome incorporation of diaminocyclohexane platinum (II) complexes
HUP0202684A3 (en) * 1999-09-14 2003-02-28 Smithkline Beecham Corp Container closure system
WO2001036431A1 (en) 1999-11-15 2001-05-25 Parker Hughes Institute Diamino platinum (ii) antitumor complexes
EP1675864B1 (en) 2003-08-13 2009-12-30 University of South Florida Platinum complexes for the treatment of tumors
US20050288365A1 (en) * 2004-01-06 2005-12-29 Heidi Kay Platinum complexes and methods for inhibiting tumor cell proliferation
WO2007008247A2 (en) * 2004-11-10 2007-01-18 University Of South Florida Platinum complexes for targeted drug delivery
WO2007006019A1 (en) * 2005-07-06 2007-01-11 University Of South Florida Materials and methods for screening, diagnosis and prognosis of conditions associated with stat protein expression
JP5378792B2 (ja) 2006-06-28 2013-12-25 株式会社Ｉｈｉ 磁性薬誘導システム
JP4774536B2 (ja) * 2006-11-06 2011-09-14 株式会社Ｉｈｉ 磁性材料、磁性材料の誘導装置及び磁性材料の設計方法
US20090169484A1 (en) 2007-12-28 2009-07-02 Ihi Corporation Iron-salen complex
CN102239138A (zh) 2008-11-20 2011-11-09 株式会社Ihi 自磁性金属salen络合物
WO2011160063A2 (en) 2010-06-18 2011-12-22 Myriad Genetics, Inc. Methods and materials for assessing loss of heterozygosity
EP2609216B1 (en) 2010-08-24 2016-06-01 Dana-Farber Cancer Institute, Inc. Methods for predicting anti-cancer response
JP6117194B2 (ja) 2011-06-17 2017-04-19 ミリアド・ジェネティックス・インコーポレイテッド アレル不均衡を評価するための方法および材料
ES2759533T5 (es) 2011-12-21 2023-06-22 Myriad Genetics Inc Métodos y materiales para evaluar la pérdida de heterocigosidad
CA2864481C (en) 2012-02-23 2020-07-14 The Children's Hospital Corporation Methods for predicting anti-cancer response
EP2859118B1 (en) 2012-06-07 2017-11-22 Institut Curie Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors
US10308986B2 (en) 2013-03-14 2019-06-04 Children's Medical Center Corporation Cancer diagnosis, treatment selection and treatment
PT2981624T (pt) 2013-04-05 2020-03-23 Myriad Genetics Inc Métodos para avaliar deficiência na recombinação homóloga e prever resposta a tratamento para cancro
EP3080292B1 (en) 2013-12-09 2022-02-02 Institut Curie Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors
EP4234711B1 (en) 2014-08-15 2025-05-28 Myriad Genetics, Inc. Methods and materials for assessing homologous recombination deficiency
EP4141127B1 (en) 2021-08-30 2024-10-09 Zentrum Familiärer Brust- und Eierstockkrebs Universitätsklinik Köln Method for assessing homologous recombination deficiency in ovarian cancer cells

Also Published As

Publication number Publication date
GB1432563A (en) 1976-04-22
JPS535369B2 (cs) 1978-02-27
JPS4913317A (cs) 1974-02-05
US3904663A (en) 1975-09-09
SE396755B (sv) 1977-10-03
DE2318021A1 (de) 1973-11-08
FR2182942A1 (cs) 1973-12-14
FR2182942B1 (cs) 1976-10-22

Similar Documents

Publication Publication Date Title
FR2182942B1 (cs)
FR2186215B1 (cs)
JPS49133501A (cs)
FR2182943B1 (cs)
JPS5139663B2 (cs)
JPS4982367U (cs)
JPS5221056Y2 (cs)
JPS4981896A (cs)
JPS4922743A (cs)
CH578813A5 (cs)
CH575247A5 (cs)
DD116594A1 (cs)
DD106199A5 (cs)
DD100096A1 (cs)
CH580160A5 (cs)
CH545715A (cs)
CH579958A5 (cs)
CH579874A5 (cs)
CH579871A5 (cs)
CH579666B5 (cs)
CH579020A5 (cs)
CH576835A5 (cs)
CH578748A5 (cs)
CH578500A5 (cs)
CH578211A5 (cs)

Legal Events

Date Code Title Description
BV The patent application has lapsed